The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.

Executive Summary and Global Market Analysis

The global cancer therapeutics market is undergoing substantial expansion, propelled by the rising global prevalence of breast and lung cancer and heightened investments in oncology research and development. Cancer therapeutics involves a diverse array of treatments aimed at managing or curing cancerous conditions. The primary therapeutic approaches include chemotherapy, radiation, immunotherapy, targeted therapies, hormone therapy, surgical procedures, and stem cell transplantation. These methods are designed to eradicate or control tumor growth, alleviate symptoms, and ultimately enhance patient prognosis. Depending on the specific cancer type, its stage, and the patient's overall health, a combination of these interventions is frequently applied to optimize treatment outcomes.

Cancer Therapeutics Market Segmentation Analysis

The in-depth analysis of the cancer therapeutics market is based on its key segments: therapy type, indication, and distribution channel.

Under therapy type, the market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other diverse therapeutic categories. Chemotherapy maintained its leading position in the market in 2024.

With respect to indications, the market is segmented to include blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other relevant indications. Lung cancer held the largest market share in 2024.

By distribution channel, the market is classified into hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies continued to hold the largest share of the market in 2024.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

Cancer Therapeutics Market Drivers and Opportunities

According to data from the World Health Organization, approximately one-sixth of all deaths worldwide are attributed to various forms of cancer. In 2022, an estimated 20 million new cancer cases were diagnosed, leading to 9.7 million cancer-related deaths. Projections indicate that this burden will escalate by roughly 77% by 2050, placing immense pressure on healthcare systems and communities globally. The American Cancer Society emphasizes that 5–10% of all cancers have an inherited genetic basis. Numerous genes predisposing individuals to cancer have been identified; for instance, mutations in genes such as BRCA1 and BRCA2 are known to elevate the risk of breast, ovarian, and prostate cancers. Breast cancer is widely considered the most common cancer among women globally, with its incidence continuously increasing due to various factors including environmental impact, genetic predisposition, hormonal imbalances, and lifestyle choices. It also remains a highly prevalent cancer in the U.S.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications